FS KKR Capital Corp Dossier - Source-backed chat

FS KKR Capital Corp

FSKNYSE

SectorFinancials

IndustryAsset Management

Beta (adjusted)0.88

Intrinsic Value

Insufficient data for a value estimateNot enough reliable inputs to publish a fair value for this company yet.

Market Price $11.11Price as of 1 Oct 2026

Data confidenceNot applicable

Market Cap $3.1B

Enterprise Value $9.4B

Shares Outstanding 280.1M diluted

Next Earnings Date5 Nov 2026

Last ex-dividend16 Sep 2026

All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference.

Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted

Thesis Summary

FS KKR Capital Corp (FSK) is navigating a highly challenging operational phase characterized by significant credit deterioration, a 9.9% sequential decline in NAV per share to $18.83 in Q1 2026, and a reset of its quarterly distribution to $0.42 per share. While the external manager (KKR) has stepped in with a comprehensive $600 million strategic support package—including a $150 million tender offer at $11.00, a $150 million convertible preferred investment, a $300 million share buyback program, and a 50% waiver of the subordinated income incentive fee—these measures primarily support the stock price rather than addressing underlying credit issues. With non-accruals rising to 4.2% on a fair value basis and multiple class-action lawsuits clouding the near-term outlook, a Hold recommendation is warranted until portfolio credit quality stabilizes.

This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.

Street view · analyst 12-month targets10 analysts · as of 18 Aug 2026

Low · most bearish analyst$9.50

Mean target$11.90

High · most bullish analyst$15.00

Our research · scenarios, merits, risks, and invalidation triggersResearch as of 18 Sep 2026

Scenarios · 12-month scenario targetsAnchored at research date

Bear CaseDownside scenario

Further credit deterioration in the legacy 2021–2022 portfolio names leads to additional non-accruals, pushing the non-accrual rate past 6% of fair value. Continued mark-to-market losses cause NAV to decay further toward $16.00 per share. The dividend is cut again to preserve capital, and the stock continues to trade at a persistent 45% discount to NAV.

Base CaseCentral scenario

The stock trades at a deep discount to NAV (approximately 0.59x), reflecting the market's skepticism regarding the valuation of its underlying loan book. Under the base case, the strategic support package and fee waivers will successfully defend the reset $0.42 quarterly dividend, while the $300 million share repurchase program will retire roughly 15% of the float, providing a floor for the stock price. Non-accruals are expected to peak in mid-2026 and gradually normalize, allowing the price-to-NAV multiple to recover to approximately 0.70x by early 2027.

Scenarios are anchored to street consensus at the research date, with our probabilities and rationale.

Key Investment Merits

Substantial $600 million strategic support package from KKR provides a strong near-term price floor and liquidity cushion.
Four-quarter 50% waiver of the subordinated income incentive fee directly supports net investment income and dividend coverage.
Aggressive $300 million share repurchase program is highly accretive to NAV per share when executed at the current deep discount.

Key Investment Risks

Elevated non-accrual rate (4.2% at fair value, 8.1% at amortized cost) indicates persistent credit stress in the underlying portfolio.
High leverage with a net debt-to-equity ratio of 131%, which is at the upper end of its peer group.
Ongoing securities class action lawsuits alleging overstated portfolio valuations and misleading disclosures create significant legal overhang.

Thesis Invalidation Triggers

A further reduction in the quarterly base distribution below $0.42 per share.
Non-accrual investments rising above 6.0% of the total portfolio at fair value.
Failure to execute the authorized $300 million share repurchase program in a timely manner.

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Explore this dossier

ValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework.